Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: Baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

by Keech, A.C, Scott, R., Best, J.
Published 2020

An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes

by Noonan, J.E., Jenkins, A.J., Ma, J.-X., Keech, A.C., Wang, J.J., Lamoureux, E.L.
Published 2016

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

by Scott, R, Donoghoe, M, Watts, G.F, O'Brien, R, Pardy, C, Taskinen, M.-R, Davis, T.M.E, Colman, P.G, Manning, P, Fulcher, G, Keech, A.C
Published 2020